UK markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6600-0.2300 (-7.96%)
At close: 04:00PM EDT
2.7000 +0.04 (+1.50%)
After hours: 07:58PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-105,814
-72,435
-41,106
-29,815
-18,496
Depreciation & amortisation
6,998
3,370
1,480
1,128
1,321
Deferred income taxes
-
-5,777
-
-
-
Stock-based compensation
18,468
9,719
1,554
1,346
1,309
Change in working capital
-21,719
-7,652
-3,440
-4,972
-2,369
Accounts receivable
-406
-493
2,087
-2,374
-900.119
Inventory
-24,418
-15,928
-4,201
-3,641
-418.984
Accounts payable
3,893
6,781
-1,809
1,362
-954.377
Other working capital
-109,265
-73,387
-38,314
-29,591
-20,276
Other non-cash items
1,593
1,481
1,264
883.269
750.474
Net cash provided by operating activities
-106,430
-71,927
-38,314
-29,530
-19,944
Cash flows from investing activities
Investments in property, plant and equipment
-2,835
-1,460
-
-61.056
-331.716
Acquisitions, net
-
-49,086
-2,450
-
-
Purchases of investments
-342,933
-313,392
-
-
-
Sales/maturities of investments
179,958
86,483
-
-
-
Other investing activities
-
-607
-
-
-
Net cash used for investing activities
-214,908
-278,062
-2,450
-61.056
-331.716
Cash flows from financing activities
Debt repayment
1,988
-15,005
-7,258
-14,427
-7,448
Common stock issued
14,076
342,711
39,934
19,556
19,390
Other financing activities
-
-1,704
-2,000
-
-
Net cash used provided by (used for) financing activities
15,943
336,111
61,902
30,379
35,776
Net change in cash
-305,395
-13,878
21,137
788.644
15,501
Cash at beginning of period
332,554
38,449
17,311
16,523
1,022
Cash at end of period
27,159
24,571
38,449
17,311
16,523
Free cash flow
Operating cash flow
-106,430
-71,927
-38,314
-29,530
-19,944
Capital expenditure
-2,835
-1,460
-
-61.056
-331.716
Free cash flow
-109,265
-73,387
-38,314
-29,591
-20,276